Abstract
The aim of the study was to explore the effect of bivalirudin by intracoronary injection during primary PCI on coronary blood flow and 30 days clinical events in patients with acute ST segment elevation myocardial infarction. This was a prospective, randomized controlled pilot trial. A total of 84
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
